| E-Folder |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Strategic Planning > What Is Knowledge Management? |
|
E-Folder - What Is Knowledge Management?
Knowledge management may refer to the ways organizations collect, manage, and use the knowledge that they obtain. Knowled According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ge management is a term applied to techniques utilized for the methodical compilation, transfer, security and management o ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in information in organizations, along with schemes designed to aid in making best use of that knowledge. Specifically, it lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. refers to tools and techniques intended to safeguard the availability of information that is held by key persons and make here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ecision-making easy. It also has a role to play in reducing risk. It is both a software market as well as an area in consu d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ltancy practice, associated with disciplines such as competitive aptitude. Knowledge management moreover designates an ap ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc roach towards enhancing organizational results and organizational learning. This is achieved with the introduction of a co easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi llection of particular processes and practices for categorizing and capturing knowledge, experience, expertise and other i nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically tellectual resources. It also implies making such knowledge assets are accessible for transfer and are able to be used ac and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ross the organization. Knowledge management programs are, in general, tied to definite organizational goals and are proje ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ted to lead to the achievement of particular targeted results such as superior performance, competitive advantage, or high ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a er levels of modernization. Knowledge transfer, an aspect of knowledge management, has constantly existed in one form or dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod nother, such as through on-the-job discussions with peers, officially through apprenticeship, specialized training and men cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin toring programs, and recently technically through knowledge bases, professional systems, and other knowledge repositories. tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen Knowledge management programs seek to intentionally appraise and manage the process of growth and application of intellect t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ual capital. Although knowledge management programs are quite similar to organizational learning initiatives, knowledge m ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust nagement may be differentiated from organizational learning due to its greater focus on the management of particular knowl y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products edge assets. The rise of knowledge management has seen a growing understanding in the difference between implied and prec . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de se knowledge. It has also witnessed refined viewpoints on management, evaluation and utilization of intellectual resources elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip , and the emergence of new managerial functions and responsibilities such as the position of Chief Knowledge Officer (CKO) tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Business Cards - This Is The Way Customer Service Starts in Selling
|